Interrogating Real-World Case Studies in Validating Computational Models Including De Novo, Generative AI & Machine Learning to Enhance Predictability Power in Biologics Discovery & Development
Welcome to the 10th CDD for Biologics Summit
The landscape of biologics discovery is rapidly evolving, driven by breakthroughs in AI, an influx of high-quality datasets, and regulatory momentum supporting in silico approaches. As industry leaders look to streamline R&D and de-risk development, there is a critical need for cutting-edge tools in modeling, characterization, screening, and developability.
Returning to Boston this fall at this opportune moment, the 10th anniversary of the CDD for Biologics Summit will unite 50+ decision-makers and industry experts from pharma and biotech to share their unfiltered lessons learned from validating and training computational models to streamline novel target validation, enhance biologics design and empower developability predictions.
This is the go-to forum for innovators across pharma and biotech to showcase current pipeline developments that can enable faster, smarter, and more scalable therapeutic design.
Diving into the latest industry applications of computational models, including physics-based, generative AI, and de novo design across multiple large molecules, including peptides, ADCs, bispecific T-cell engagers, multi-specifics, vaccines, and more.
2025 AGENDA LIVE NOW
Expert Speaker Faculty
Norbert Furtmann
Group Leader & Head of Artificial Intelligence Innovation Nanobody Platform, Computational & High-throughput Protein Engineering
Sanofi
Shipra Malhotra
Senior Scientist - Biologics, Computational & Machine Learning
Takeda Pharmaceutical
What To Expect
Dive into Lab-in-the-loop AI validation systems for integrating experimental feedback into AI pipelines to refine de novo biologic designs in real-time
Learn how to avoid misleading conclusions by adopting statistically rigorous model performance assessments
Understand the adaptations or de novo design tools needed to predict efficacy, binding, and developability in multi-component biologics
Explore case studies highlighting where early integration of cross-functional perspectives led to more impactful outcomes
Our 2025 Partner
Companies in the Room
Hear From Previous Attendees
"I see immense value in attending the Annual CDD for Biologics Summit. This event provides a unique opportunity to stay abreast of cutting-edge computational methods and best practices in biologics research"
Teva Pharmaceuticals
"CDD provides an opportunity to go beyond the hype of AI/ML and discuss with other practitioners in the field the details of what the technology can do today."
Adimab